Cebix Receives $12,938,338 New Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4ff21f5f-e47f-41d7-ab27-9b07cbd51ea2&Preview=1 -
Date
9/13/2012 -
Company Name
Cebix -
Mailing Address
1298 Prospect Street La Jolla, CA 92037 -
Company Description
Cebix is focused on the development of chronic replacement therapy based on human proinsulin C-peptide for the treatment of type 1 diabetic neuropathy. The role of C-peptide will also be explored in type 1 diabetic nephropathy and retinopathy. -
Website
http://www.cebix.com -
Transaction Type
Venture Equity -
Transaction Amount
$12,938,338 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
